At West Penn Hospital in Bloomfield, a large, futuristic machine stands as one of the centerpieces of a new 9,000-square-foot AHN Skin Cancer Center. Resembling a giant airport scanner, the VECTRA imaging system uses 92 cameras to scan every inch of a patient’s body and create 3D imagery mapping every mole and lesion.
The device uses artificial intelligence to try to flag moles that might be cancerous. But perhaps more importantly, it creates a record for comparison.
“The beauty and power of the device is the longitudinal study,” said Howard Edington, director of the Melanoma and Skin Cancer Center at AHN. “The same patient comes back in a year to have another scan recorded, and the machine will be able to tell us which lesions have changed and where they are. We can then target those lesions for biopsy.”

According to AHN, the VECTRA WB360 Whole Body Imaging System is one of only 15 such devices in operation in the country.
The VECTRA machine is particularly attractive for use with patients at high risk for skin cancer or those who are difficult to examine.
One recent patient who came in for a scan had more than 700 moles and another had over 2,000, said Edington. Each of those moles had the potential to develop into a cancerous lesion, and tracking so many moles would be difficult for even the most experienced dermatologist.
While the VECTRA device is experimenting with artificial intelligence to diagnose lesions, it is certainly not a substitute for a medical opinion at this point.
“We’re not here to replace dermatology,” said Edington. “We’re here to help the dermatology community as best we can. For those patients that are extremely high risk or difficult to examine, I think the machine will be very helpful.”

Scans by the VECTRA machine are not currently covered by insurance, said Edington, and a scan costs $250 out of pocket. “For the average person on the street that’s very low risk, doesn’t have a lot of moles, maybe that’s not something they want to do,” he said of the cost. But for the high-risk patients concerned about tracking moles that AHN has seen thus far, “most patients don’t blink an eye right now.”
The scanning machine is just one piece of the new AHN Skin Cancer Center, which officially opened this month and will house cancer professionals including dermatologists, surgeons, radiologists, social workers and pathologists. It will also feature research facilities.
While the facility is in use, some portions are still under construction or awaiting final licensing.
Skin cancer is the most common type of cancer in the U.S., with about 3.5 million cases diagnosed per year. The vast majority of skin cancer cases are either basal cell carcinoma or squamous cell carcinoma — both generally easy to treat and unlikely to spread if caught early, said Edington.
Melanoma only accounts for 1% of skin cancer cases but causes the vast majority of deaths. Melanoma cases are increasing, said Edington, with the global melanoma rate projected to increase 50% by 2040.
Anya Sostek: asostek@post-gazette.com




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.